Skip to main content

β-Cell Regeneration in Human Pancreas

The Lessons of Pancreatic Pathology

  • Chapter
  • First Online:
Diabetes

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 771))

Abstract

Diabetes mellitus has been traditionally classified as Type 1 and Type 2 on the basis of several criteria that generally reflect either insulin deficiency or functional defects in insulin secretion. In this chapter, we propose a new classification diabetes based on age of onset, body mass index and biomarkers such as islet autoantibodies and DR HLA alleles. In the second part of this chapter, we briefly discuss some novel hypotheses on the possibility of β-cell regeneration in diabetes in relation to the islet pathology of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Orsi CM, Hale DE, Lynch JL. Pediatric obesity epidemiology. Curr Opin Endocrinol Diabetes Obes 2011; 18:14–22.

    Article  PubMed  Google Scholar 

  2. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2:1279–83.

    Article  CAS  PubMed  Google Scholar 

  3. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 1981 Dec 19–26; 2(8260–61):1363–5.

    Google Scholar 

  4. Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev 2005; 204:232–49.

    Article  CAS  PubMed  Google Scholar 

  5. Srikanta S, Ricker AT, McCulloch DK et al. Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes 1986; 35:139–42.

    Article  CAS  PubMed  Google Scholar 

  6. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011; 57:168–75. Epub 2010 Dec 2.

    Article  CAS  PubMed  Google Scholar 

  7. Kawasaki E, Nakamura K, Kuriya G et al. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab 2010; 95:707–13. Epub 2010 Jan 8.

    Article  CAS  PubMed  Google Scholar 

  8. Orban T, Sosenko JM, Cuthbertson D et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009; 32:2269–74. Epub 2009 Sep 9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Uibo R, Lernmark A. GAD65 autoimmunity-clinical studies. Adv Immunol 2008; 100:39–78.

    Article  CAS  PubMed  Google Scholar 

  10. Eisenbarth GS, Jeffrey J. The natural history of type 1A diabetes. Arq Bras Endocrinol Metabol 2008; 52:146–55.

    Article  PubMed  Google Scholar 

  11. Ismail D, Werther G. Persistent hyperinsulinaemic hypoglycaemia of infancy: 15 years’ experience at the Royal Children’s Hospital (RCH). Melbourne. J Pediatr Endocrinol Metab 2005; 18:1103–9.

    PubMed  Google Scholar 

  12. Giurgea I, Bellanné-Chantelot C, Ribeiro M et al. Molecular mechanisms of neonatal hyperinsulinism. Horm Res 2006; 66:289–96. Epub 2006 Sep 26.

    CAS  PubMed  Google Scholar 

  13. Christesen HB, Brusgaard K, Alm J et al. Rapid genetic analysis in congenital hyperinsulinism. Horm Res 2007; 67:184–8. Epub 2006 Nov 15.

    CAS  PubMed  Google Scholar 

  14. Cherian MP, Abduljabbar MA. 14. Persistent hyperinsulinemic hypoglycemia of infancy (PHHI): Long-term outcome following 95% pancreatectomy. J Pediatr Endocrinol Metab 2005; 18:1441–8.

    Article  PubMed  Google Scholar 

  15. Leibowitz G, Glaser B, Higazi AA et al. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab 1995; 80:386–92.

    CAS  PubMed  Google Scholar 

  16. Conget I, Sarri Y, Somoza N et al. Beta-cell function abnormalities in islets from an adult subject with nesidioblastosis and autoantibodies against the islet cells. Pancreas 1997; 14:71–5.

    Article  CAS  PubMed  Google Scholar 

  17. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Dracoulacos D et al. Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. J Pediatr Endocrinol Metab 2000; 13: 319–24.

    Article  CAS  PubMed  Google Scholar 

  18. Pont A, Rubino JM, Bishop D. Diabetes mellitus and neuropathy following Vacor ingestion in man. Arch Intern Med 1979; 139:185–7.

    Article  CAS  PubMed  Google Scholar 

  19. Gumus P, Gomez R, Vargas A et al. The relationship of insulin secretion and GAD65 antibody levels at diagnosis on glycemic control in type 2 diabetes. J Pediatr Endocrinol Metab 2010; 23:1025–9.

    Article  CAS  PubMed  Google Scholar 

  20. Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem 2011; 57:176–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Borg H, Gottsäter A, Fernlund P et al. Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab 1999; 10:142–6.

    Article  Google Scholar 

  22. Borg H, Gottsäter A, Fernlund P et al. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002; 51: 1754–62.

    Article  CAS  PubMed  Google Scholar 

  23. Jurgens CA, Toukatly MN, Fligner CL et al. β-Cell Loss and β-Cell Apoptosis in Human Type 2 Diabetes Are Related to Islet Amyloid Deposition. Am J Pathol 2011; 178:2632–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. .Rodríguez-Villar C, Conget I, Esmatjes E et al. Presence of markers predictive of type I pre-diabetes mellitus status in relatives of patients with type I diabetes mellitus. Med 1996; 107:371–4.

    Google Scholar 

  25. Luijf YM, Hermanides J, Serlie MJ et al. The added value of oral glucose tolerance testing in pre-diabetes. Curr Diabetes Rev 2011; 7:56–60.

    Article  CAS  PubMed  Google Scholar 

  26. Siljander HT, Veijola R, Reunanen A et al. Prediction of type 1 diabetes among siblings of affected children and in the general population. Diabetologia 2007; 50:2272–5.

    Article  CAS  PubMed  Google Scholar 

  27. Atkinson MA, Gianani R. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diabetes Obes 2009; 16: 279–85.

    Article  PubMed  Google Scholar 

  28. In’t Veld P, Lievens D, De Grijse J et al. Screening for Insulitis in Adult Autoantibody-Positive Organ Donors Diabetes 2007; 56:2400–4.

    Article  CAS  Google Scholar 

  29. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619–33.

    Article  CAS  PubMed  Google Scholar 

  30. Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 1991; 165:97–103.

    Article  CAS  PubMed  Google Scholar 

  31. Rubio-Cabezas O, Klupa T, Malecki MT; CEED3 Consortium. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest 2011; 41:323–33.

    Article  PubMed  Google Scholar 

  32. Gianani R, Campbell-Thompson M, Sarkar SA et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 2010; 53:690–8.

    Article  CAS  PubMed  Google Scholar 

  33. Liggins C, Orlicky DJ, Bloomquist LA et al. Developmentally regulated expression of Survivin in human pancreatic islets. Pediatr Dev Pathol 2003; 6:392–7.

    Article  CAS  PubMed  Google Scholar 

  34. Hasel C, Bhanot UK, Heydrich R et al. Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NFkappaB and IAPs. Lab Invest 2005; 85:1263–75.

    Article  CAS  PubMed  Google Scholar 

  35. Gianani R, Putnam A, Still T et al. Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 2006; 91:1855–61.

    Article  CAS  PubMed  Google Scholar 

  36. Jiang Y, Nishimura W, Devor-Henneman D et al. Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes 2008; 57:2718–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Keenan HA, Sun JK, Levine J et al. Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010; 59:2846–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Gianani .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Landes Bioscience and Springer Science+Business Media

About this chapter

Cite this chapter

Maulis, M., Gianani, R. (2013). β-Cell Regeneration in Human Pancreas. In: Ahmad, S.I. (eds) Diabetes. Advances in Experimental Medicine and Biology, vol 771. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5441-0_23

Download citation

Publish with us

Policies and ethics